Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Published:2020-08 Issue:10249 Volume:396 Page:479-488
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zhu Feng-Cai,Guan Xu-Hua,Li Yu-Hua,Huang Jian-Ying,Jiang Tao,Hou Li-Hua,Li Jing-Xin,Yang Bei-Fang,Wang Ling,Wang Wen-Juan,Wu Shi-Po,Wang Zhao,Wu Xiao-Hong,Xu Jun-Jie,Zhang Zhe,Jia Si-Yue,Wang Bu-Sen,Hu Yi,Liu Jing-Jing,Zhang Jun,Qian Xiao-Ai,Li Qiong,Pan Hong-Xing,Jiang Hu-Dachuan,Deng Peng,Gou Jin-Bo,Wang Xue-Wen,Wang Xing-Huan,Chen Wei

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. Rapid COVID-19 vaccine development;Graham;Science,2020

2. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset;Cheng;JAMA Intern Med,2020

3. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment;Leung;Lancet,2020

4. Developing COVID-19 vaccines at pandemic speed;Lurie;N Engl J Med,2020

5. Developing a vaccine for covid-19;Caddy;BMJ,2020

Cited by 1119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications;Molecular Therapy - Methods & Clinical Development;2024-09

3. Bioproduction and immunogenic evaluation of SARS-CoV-2 prototype vaccine in silkworm BmN cells;International Journal of Biological Macromolecules;2024-09

4. Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters;Frontiers in Immunology;2024-08-30

5. Beyond COVID-19: the promise of next-generation coronavirus vaccines;npj Viruses;2024-08-22